Evidence map›Paper›PMID 41950480›Full record

ArticleThe New England journal of medicine2026

Trends in Youth-Onset Type 2 Diabetes, 2013-2024.

Michael Fang, Yunwen Xu, Elizabeth Selvin, Jung-Im Shin

Abstract readLetter
In one paragraph

Article in The New England journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael FangJohns Hopkins Bloomberg School of Public Health, Baltimore.ORCID 0000-0003-2849-1780
Yunwen XuJohns Hopkins Bloomberg School of Public Health, Baltimore.
Elizabeth SelvinJohns Hopkins Bloomberg School of Public Health, Baltimore.ORCID 0000-0001-6923-7151
Jung-Im ShinJohns Hopkins Bloomberg School of Public Health, Baltimore.

Funding

Medication Use and Adverse Events in CKDR01DK115534 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Alexander R Chang, Morgan Erika Grams · 2018 to 2026
$5.7M
Challenges to Guideline-Recommended Diabetes Care in the United StatesR01DK139324 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Jung-Im Shin · 2025 to 2026
$1.4M
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 DiabetesK24HL152440 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SELVIN, ELIZABETH · 2020 to 2024
$612k
Disparities in the management and prognosis of type 1 diabetesK01DK138273 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Michael Fang · 2024 to 2026
$470k
American Heart Association MERIT awardAmerican Heart Association-American Stroke Association 25MERIT1415983NHLBI NIH HHS K24 HL152440NIDDK NIH HHS K01 DK138273NIDDK NIH HHS K01DK138273NIDDK NIH HHS R01 DK115534NIDDK NIH HHS R01DK115534NIDDK NIH HHS R01 DK139324NIDDK NIH HHS R01DK139324
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41950480
PMCPMC13108512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.